Knowledge Center

Article / Jan 01, 2004

Selecting lactose for a capsule-based dry powder inhaler

Authors:
  • Hartwig Steckel
  • Fadi Eskandar
  • Peter Villax
Source:
Pharmaceutical Technology Europe (2004), 16(4), 23

Dry powder inhalers are a well-accepted dosage form for pulmonary drug delivery and a wide variety are either currently available or development. This article examines a premetered, capsule-based multidose inhaler for which different qualities of _-lactose monohydrate were screened.

Also in the Knowledge Center

Related Content

Drug Product Manufacturing

To extend Hovione further we are now able to offer clinical supplies manufacturing for drug products.

Page
Read more

Sustainability

At Hovione, sustainability is not just an aspiration - it is a fundamental component of our strategy and daily operations. Embedded deeply within our DNA, sustainability is brought to life by the commitment and actions of every member of our team.

Page
Read more

Dispersome®

Make your drug soluble with Dispersome® technology. Dispersome® is a solubility enhancement technology that relies on an innovative and naturally occurring excipient to develop amorphous solid dispersions with high drug loading and high bioavailability.

Page
Read more